Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: A 12-month follow-up study
Background: Oral minipulse (OMP) therapy with methylprednisolone is presently one of the most common oral treatments used for progressive vitiligo in children. The treatment is usually given for a period of 6 months during which majority of patients are reported to go into remission. However, there...
Saved in:
Main Authors: | Imran Majid (Author), Saher Imran (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Childhood vitiligo : Response to methylprednisolone oral minipulse therapy and topical fluticasone combination
by: Majid Imran, et al.
Published: (2009) -
Comparative study of intravenous methylprednisolone pulse therapy versus oral prednisolone minipulse therapy in progressive vitiligo
by: K A Rajeshwari, et al.
Published: (2023) -
Comparative Study Of PUVASOL And Oral Corticosteroid Minipulse In The Treatment Of Vitiligo
by: Huda M.M, et al.
Published: (2002) -
Oral Pemphigus treated with minipulse therapy.
by: Kundoor Vinay Kumar Reddy, et al.
Published: (2018) -
A randomized controlled study to compare the efficacy of methotrexate vs. oral minipulse (betamethasone) along with NBUVB in patients with vitiligo vulgaris
by: Ashish Deshmukh, et al.
Published: (2020)